Microbix Biosystems Inc.
MBXBF
$0.2992
$0.00511.73%
| Weiss Ratings | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C+ | |||
| Rating Factors | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.55 | |||
| Price History | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.86% | |||
| 30-Day Total Return | -14.51% | |||
| 60-Day Total Return | 3.17% | |||
| 90-Day Total Return | 36.31% | |||
| Year to Date Total Return | 3.53% | |||
| 1-Year Total Return | 5.17% | |||
| 2-Year Total Return | 8.37% | |||
| 3-Year Total Return | -43.45% | |||
| 5-Year Total Return | 76.00% | |||
| 52-Week High % Change | -24.01% | |||
| 52-Week Low % Change | 47.05% | |||
| Price | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.39 | |||
| 52-Week Low Price | $0.20 | |||
| 52-Week Low Price (Date) | Dec 02, 2024 | |||
| 52-Week High Price (Date) | Feb 14, 2025 | |||
| Valuation | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 42.02M | |||
| Enterprise Value | 37.43M | |||
| Price/Earnings (TTM) | 29.41 | |||
| Earnings Per Share (TTM) | 0.01 | |||
| Earnings Per Share Growth | -49.49% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 2.37 | |||
| Price/Book (Q) | 1.97 | |||
| Enterprise Value/Revenue (TTM) | 2.15 | |||
| Price | $0.30 | |||
| Enterprise Value/EBITDA (TTM) | 13.02 | |||
| Enterprise Value/EBIT | 21.58 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 135.55M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 905 361 8910 | |||
| Address | 265 Watline Avenue Mississauga, ON L4Z 1P3 | |||
| Website | www.microbix.com | |||
| Country | Canada | |||
| Year Founded | 1988 | |||
| Profitability | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 9.96% | |||
| Profit Margin | 8.30% | |||
| Management Effectiveness | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 3.80% | |||
| Return on Equity | 6.86% | |||
| Income Statement | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 16.81M | |||
| Total Revenue (TTM) | 16.81M | |||
| Revenue Per Share | $0.12 | |||
| Gross Profit (TTM) | 9.42M | |||
| EBITDA (TTM) | 2.78M | |||
| EBIT (TTM) | 1.68M | |||
| Net Income (TTM) | 1.40M | |||
| Net Income Avl. to Common (TTM) | 1.40M | |||
| Total Revenue Growth (Q YOY) | -30.13% | |||
| Earnings Growth (Q YOY) | -66.08% | |||
| EPS Diluted (TTM) | 0.01 | |||
| EPS Diluted Growth (Q YOY) | -67.42% | |||
| Balance Sheet | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 9.07M | |||
| Cash Per Share (Q) | $0.07 | |||
| Total Current Assets (Q) | 17.86M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 20.09M | |||
| Current Ratio (Q) | 6.625 | |||
| Book Value Per Share (Q) | $0.15 | |||
| Total Assets (Q) | 27.31M | |||
| Total Current Liabilities (Q) | 2.70M | |||
| Total Debt (Q) | 4.48M | |||
| Total Liabilities (Q) | 7.23M | |||
| Total Common Equity (Q) | 20.09M | |||
| Cash Flow | MBXBF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.52M | |||
| Cash from Financing (TTM) | -1.06M | |||
| Net Change in Cash (TTM) | 193.70K | |||
| Levered Free Cash Flow (TTM) | 415.50K | |||
| Cash from Operations (TTM) | 2.78M | |||
